Analyst firms · BofA Securities · BMY
BofA Securities BMY price target and rating history
Bristol-Myers Squibb Company (BMY) · Health Care
BofA Securities rates Bristol-Myers Squibb Company (BMY) Buy with a $61 price target, as of its latest action on Dec 15, 2025. It has published 3 rating actions on BMY since January 2024, including 1 upgrade and 1 downgrade. Across 7 firms with a BMY price target in the last 12 months, the median target is $62. BofA Securities's $61 is 2% below that.
- Current rating
- Buy
- Price target
- $61
- Median target, all firms
- $62
- Actions on BMY
- 3
BofA Securities price target on BMY
Every BofA Securities rating on BMY
- Dec 15, 2025
- Dec 10, 2024
- Jan 3, 2024
How other firms rate BMY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Leerink Partners | Market Perform | $59 | Oct 5, 2026 |
| Argus Research | Buy | $75 | Aug 5, 2026 |
| RBC Capital Markets | Sector Perform | $60 | Feb 25, 2026 |
| Barclays | Overweight | $75 | Feb 20, 2026 |
| UBS | Buy | $65 | Jan 7, 2026 |
| BofA Securities | Buy | $61 | Dec 15, 2025 |
| Guggenheim | Buy | $62 | Dec 12, 2025 |
Questions about BofA Securities and BMY
- What is BofA Securities's price target for BMY?
- BofA Securities's latest stated price target for Bristol-Myers Squibb Company (BMY) is $61, from its action on Dec 15, 2025.
- What is BofA Securities's rating on BMY?
- BofA Securities rates BMY Buy, a bullish rating, as of Dec 15, 2025.
- When did BofA Securities last change its view on BMY?
- On Dec 15, 2025, BofA Securities upgrades to Buy from Neutral, price target $61.
- How does BofA Securities's BMY target compare with other analysts?
- Across 7 firms with a BMY price target in the last 12 months, the median target is $62. BofA Securities's $61 is 2% below that.
More BMY rating histories
All BofA Securities ratingsBMY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.